Table 2.
Regression Models and Effect Sizes for ASPD Symptoms: Full Sample Analyses
| Extent of ASPD Symptoms | |||||
|---|---|---|---|---|---|
| FΔ | df | P | R2Δ | β | |
| Model 1: | |||||
| Step 1 | |||||
| Male gender | 13.73 | 1, 106 | .000 | .12 | .34*** |
| Step 2 | |||||
| Early clinical risk | 3.55 | 2,104 | .03* | .06 | |
| Early clinical risk vs longitudinal comparison | .28* | ||||
| Early clinical risk vs cross-sectional comparison | .28** | ||||
| | |||||
| Model 2: | |||||
| Step 1 | |||||
| Male gender | 13.73 | 1, 106 | .000 | .12 | .34*** |
| Step 2 | |||||
| Childhood abuse | 5.07 | 1,105 | .03 | .04 | .22* |
| Model 3: Evaluating Mediation by Childhood Abuse | |||||
| Step 1 | |||||
| Gendera | 13.73 | 1,106 | .000 | .12 | .34*** |
| Step 2 | |||||
| Childhood abuse | 5.07 | 1, 105 | .03 | .04 | .20* |
| Step 3 | |||||
| Early clinical risk | 4.59 | 1, 104 | .04 | .04 | .20* |
Note. N = 108.